Linezolid Accordpharma

Linezolid, the active ingredient in Linezolid Accordpharma, is an oxazolidinone presented as an intravenous formulation for the treatment of serious Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients.

GNH USA supplies Linezolid Accordpharma as a licensed, EU‑origin, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this antibiotic for qualified healthcare providers.

Linezolid is an oxazolidinone antibiotic used to treat infections caused by resistant Gram‑positive bacteria.

- Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective for skin, soft‑tissue and pneumonia caused by MRSA. - Vancomycin‑resistant Enterococcus (VRE) infections: provides an alternative option for VRE bloodstream and urinary infections. - Community‑acquired and hospital‑acquired pneumonia: active against typical pathogens, reducing disease severity. - Skin and soft tissue infections: treats complicated infections where other agents may fail.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: mild to moderate loose stools. - Headache: occasional tension‑type headache. - Vomiting: occasional episodes. - Metallic taste: transient dysgeusia. - Myelosuppression (early): mild decrease in blood cell counts.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduction in red blood cell levels. - Peripheral neuropathy: numbness or tingling in extremities. - Optic neuropathy: visual disturbances, potentially irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Severe hypersensitivity: rash, angioedema, or anaphylaxis.

When prescribing Linezolid, clinicians should consider several safety measures.

- Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic impairment: assess liver enzymes periodically. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Myelosuppression: perform regular complete blood counts. - Pregnancy and lactation: use only if benefits outweigh potential risks; safety not established. - Store at below 25°C: keep in the original container, protect from moisture and light.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs: risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): increased serotonergic effects. - Rifampicin: reduces linezolid plasma concentrations, potentially compromising efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR. - Cyclosporine: possible increased toxicity; observe renal function. - Theophylline: may increase plasma concentrations; monitor for toxicity.